Kragl Angelique, Schoon Janosch, Tzvetkova Ana, Wenzel Christoph, Blaschke Martina, Böcker Wolfgang, Siggelkow Heide, Tzvetkov Mladen V
Institute of Pharmacology, Center of Drug Absorption and Transport (C_DAT), University Medicine Greifswald, Greifswald, Germany.
Center for Orthopaedics, Trauma Surgery and Rehabilitation Medicine, University Medicine Greifswald, Greifswald, Germany.
Front Bioeng Biotechnol. 2022 Aug 25;10:953034. doi: 10.3389/fbioe.2022.953034. eCollection 2022.
Exogenous glucocorticoids increase the risk for osteoporosis, but the role of endogenous glucocorticoids remains elusive. Here, we describe the generation and validation of a loss- and a gain-of-function model of the cortisol producing enzyme 11β-HSD1 () to modulate the endogenous glucocorticoid conversion in SCP-1 cells - a model for human mesenchymal stem cells capable of adipogenic and osteogenic differentiation. CRISPR-Cas9 was successfully used to generate a cell line carrying a single base duplication and a 5 bp deletion in exon 5, leading to missense amino acid sequences after codon 146. These inactivating genomic alterations were validated by deep sequencing and by cloning with subsequent capillary sequencing. 11β-HSD1 protein levels were reduced by 70% in the knockout cells and cortisol production was not detectable. Targeted chromosomal integration was used to stably overexpress . Compared to wildtype cells, overexpression resulted in a 7.9-fold increase in mRNA expression, a 5-fold increase in 11β-HSD1 protein expression and 3.3-fold increase in extracellular cortisol levels under adipogenic differentiation. The generated cells were used to address the effects of 11β-HSD1 expression on adipogenic and osteogenic differentiation. Compared to the wildtype, overexpression led to a 3.7-fold increase in mRNA expression of lipoprotein lipase and 2.5-fold increase in lipid production under adipogenic differentiation. Under osteogenic differentiation, knockout led to enhanced alkaline phosphatase (ALP) activity and mRNA expression, and overexpression resulted in a 4.6-fold and 11.7-fold increase in mRNA expression of Dickkopf-related protein 1 and , respectively. Here we describe a loss- and gain-of-function model in SCP-1 cells at genetic, molecular and functional levels. We used these models to study the effects of endogenous cortisol production on mesenchymal stem cell differentiation and demonstrate an 11β-HSD1 dependent switch from osteogenic to adipogenic differentiation. These results might help to better understand the role of endogenous cortisol production in osteoporosis on a molecular and cellular level.
外源性糖皮质激素会增加骨质疏松症的风险,但内源性糖皮质激素的作用仍不明确。在此,我们描述了一种皮质醇生成酶11β - HSD1功能缺失和功能获得模型的构建及验证,以调节SCP - 1细胞中的内源性糖皮质激素转化——SCP - 1细胞是一种能够进行脂肪生成和成骨分化的人间充质干细胞模型。CRISPR - Cas9成功用于生成一个细胞系,该细胞系在第5外显子中有一个单碱基重复和一个5 bp缺失,导致密码子146之后的错义氨基酸序列。这些失活的基因组改变通过深度测序和随后的克隆及毛细管测序进行了验证。敲除细胞中11β - HSD1蛋白水平降低了70%,且未检测到皮质醇产生。通过靶向染色体整合实现了的稳定过表达。与野生型细胞相比,过表达导致在脂肪生成分化条件下,mRNA表达增加7.9倍,11β - HSD1蛋白表达增加5倍,细胞外皮质醇水平增加3.3倍。所生成的细胞用于研究11β - HSD1表达对脂肪生成和成骨分化的影响。与野生型相比,过表达导致在脂肪生成分化条件下脂蛋白脂肪酶的mRNA表达增加3.7倍,脂质生成增加2.5倍。在成骨分化条件下,敲除导致碱性磷酸酶(ALP)活性和mRNA表达增强,而过表达分别导致Dickkopf相关蛋白1和的mRNA表达增加4.6倍和11.7倍。在此,我们在基因、分子和功能水平上描述了SCP - 1细胞中的一种功能缺失和功能获得模型。我们利用这些模型研究内源性皮质醇产生对间充质干细胞分化的影响,并证明了一种依赖11β - HSD1的从成骨分化向脂肪生成分化的转变。这些结果可能有助于在分子和细胞水平上更好地理解内源性皮质醇产生在骨质疏松症中的作用。